Nutan Sharma, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dystonic Disorders | 35 | 2024 | 354 | 5.490 |
Why?
|
Dystonia | 24 | 2024 | 378 | 4.790 |
Why?
|
Genetic Diseases, X-Linked | 14 | 2024 | 386 | 1.740 |
Why?
|
Molecular Chaperones | 14 | 2016 | 762 | 1.360 |
Why?
|
Globus Pallidus | 4 | 2017 | 250 | 1.070 |
Why?
|
GTP Cyclohydrolase | 3 | 2017 | 47 | 0.960 |
Why?
|
Dystonia Musculorum Deformans | 8 | 2016 | 158 | 0.920 |
Why?
|
Dysphonia | 3 | 2021 | 144 | 0.900 |
Why?
|
Deep Brain Stimulation | 8 | 2020 | 847 | 0.830 |
Why?
|
5' Untranslated Regions | 2 | 2013 | 255 | 0.730 |
Why?
|
Conversion Disorder | 2 | 2021 | 202 | 0.700 |
Why?
|
TATA-Binding Protein Associated Factors | 5 | 2020 | 103 | 0.640 |
Why?
|
Apoptosis Regulatory Proteins | 4 | 2021 | 1151 | 0.620 |
Why?
|
Parkinsonian Disorders | 5 | 2024 | 285 | 0.560 |
Why?
|
Transcription Factor TFIID | 6 | 2020 | 150 | 0.550 |
Why?
|
Torticollis | 3 | 2016 | 69 | 0.540 |
Why?
|
Chorea | 2 | 2016 | 80 | 0.480 |
Why?
|
Histone Acetyltransferases | 5 | 2020 | 335 | 0.460 |
Why?
|
Lewy Bodies | 4 | 2002 | 141 | 0.430 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 2013 | 83 | 0.420 |
Why?
|
Brain Stem | 2 | 2021 | 862 | 0.400 |
Why?
|
Anti-Dyskinesia Agents | 2 | 2014 | 24 | 0.390 |
Why?
|
Tourette Syndrome | 2 | 2025 | 400 | 0.370 |
Why?
|
DNA Repeat Expansion | 3 | 2024 | 74 | 0.360 |
Why?
|
Mutation | 15 | 2022 | 30230 | 0.350 |
Why?
|
DNA Mutational Analysis | 2 | 2016 | 4120 | 0.340 |
Why?
|
DNA-Binding Proteins | 5 | 2021 | 9618 | 0.320 |
Why?
|
Parkinson Disease | 5 | 2018 | 2893 | 0.320 |
Why?
|
Basal Ganglia | 1 | 2012 | 555 | 0.320 |
Why?
|
Genetic Predisposition to Disease | 5 | 2024 | 18047 | 0.320 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2024 | 16027 | 0.310 |
Why?
|
Synaptic Transmission | 3 | 2010 | 1175 | 0.290 |
Why?
|
Eukaryotic Initiation Factor-2 | 2 | 2020 | 178 | 0.290 |
Why?
|
Family Health | 1 | 2011 | 1255 | 0.260 |
Why?
|
Nuclear Proteins | 4 | 2016 | 5802 | 0.260 |
Why?
|
Age of Onset | 4 | 2025 | 3345 | 0.250 |
Why?
|
Huntington Disease | 2 | 2022 | 1147 | 0.250 |
Why?
|
Brain | 11 | 2021 | 27452 | 0.240 |
Why?
|
Nerve Tissue Proteins | 5 | 2012 | 4414 | 0.240 |
Why?
|
Botulinum Toxins | 1 | 2006 | 189 | 0.240 |
Why?
|
Sodium Oxybate | 1 | 2024 | 36 | 0.230 |
Why?
|
Deglutition Disorders | 2 | 2021 | 641 | 0.230 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7145 | 0.230 |
Why?
|
Tic Disorders | 1 | 2025 | 140 | 0.220 |
Why?
|
Retroelements | 3 | 2022 | 162 | 0.220 |
Why?
|
Codon | 2 | 2017 | 599 | 0.220 |
Why?
|
Substantia Nigra | 3 | 2002 | 348 | 0.220 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2015 | 103 | 0.220 |
Why?
|
eIF-2 Kinase | 3 | 2022 | 146 | 0.210 |
Why?
|
Mutation, Missense | 4 | 2021 | 2593 | 0.210 |
Why?
|
Open Reading Frames | 2 | 2017 | 812 | 0.200 |
Why?
|
Short Interspersed Nucleotide Elements | 2 | 2018 | 41 | 0.190 |
Why?
|
Humans | 71 | 2025 | 768298 | 0.190 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2021 | 85 | 0.180 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2023 | 219 | 0.180 |
Why?
|
Nervous System Diseases | 2 | 2024 | 1664 | 0.180 |
Why?
|
Neural Stem Cells | 3 | 2018 | 891 | 0.180 |
Why?
|
Corpus Striatum | 5 | 2016 | 1236 | 0.180 |
Why?
|
Hyperkinesis | 2 | 2021 | 88 | 0.170 |
Why?
|
Algorithms | 1 | 2021 | 14154 | 0.170 |
Why?
|
Speech Disorders | 1 | 2021 | 180 | 0.170 |
Why?
|
Histones | 2 | 2020 | 2593 | 0.170 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2022 | 171 | 0.170 |
Why?
|
RNA-Binding Proteins | 4 | 2022 | 1883 | 0.170 |
Why?
|
Male | 38 | 2025 | 364870 | 0.160 |
Why?
|
Penetrance | 1 | 2021 | 384 | 0.160 |
Why?
|
PubMed | 1 | 2019 | 130 | 0.150 |
Why?
|
Movement Disorders | 1 | 2002 | 464 | 0.150 |
Why?
|
Cross-Over Studies | 1 | 2024 | 2106 | 0.150 |
Why?
|
Muscles | 1 | 2023 | 1582 | 0.150 |
Why?
|
Interferon Type I | 1 | 2022 | 569 | 0.150 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2017 | 94 | 0.150 |
Why?
|
Myelin Sheath | 1 | 2021 | 653 | 0.140 |
Why?
|
Spasms, Infantile | 1 | 2021 | 301 | 0.140 |
Why?
|
Stereotypic Movement Disorder | 1 | 2017 | 31 | 0.140 |
Why?
|
Voice | 1 | 2020 | 268 | 0.140 |
Why?
|
Epilepsy | 2 | 2021 | 3326 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2021 | 22292 | 0.140 |
Why?
|
Adult | 23 | 2025 | 223622 | 0.140 |
Why?
|
Phenotype | 8 | 2021 | 16716 | 0.140 |
Why?
|
Female | 32 | 2025 | 397050 | 0.130 |
Why?
|
Genetic Loci | 3 | 2021 | 2630 | 0.130 |
Why?
|
Ubiquitin | 1 | 2001 | 843 | 0.130 |
Why?
|
Motor Activity | 2 | 2010 | 2720 | 0.130 |
Why?
|
Receptors, Dopamine | 2 | 2015 | 296 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 697 | 0.130 |
Why?
|
Gene Expression | 5 | 2015 | 7595 | 0.130 |
Why?
|
Learning | 1 | 2005 | 1760 | 0.130 |
Why?
|
Rett Syndrome | 1 | 2017 | 164 | 0.130 |
Why?
|
Voice Disorders | 1 | 2019 | 286 | 0.120 |
Why?
|
Lewy Body Disease | 3 | 2002 | 253 | 0.120 |
Why?
|
Fibroblasts | 4 | 2020 | 4175 | 0.120 |
Why?
|
Receptors, Dopamine D2 | 2 | 2009 | 487 | 0.120 |
Why?
|
Synucleins | 4 | 2002 | 108 | 0.120 |
Why?
|
Dopamine | 4 | 2010 | 1617 | 0.120 |
Why?
|
Signal Transduction | 5 | 2020 | 23629 | 0.120 |
Why?
|
Carrier Proteins | 3 | 2002 | 4940 | 0.110 |
Why?
|
Adolescent | 12 | 2025 | 89182 | 0.110 |
Why?
|
Middle Aged | 18 | 2024 | 223463 | 0.110 |
Why?
|
Young Adult | 9 | 2025 | 60048 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 1 | 2020 | 1967 | 0.100 |
Why?
|
Genotype | 5 | 2016 | 13038 | 0.100 |
Why?
|
Tubulin | 1 | 2016 | 694 | 0.100 |
Why?
|
Sequence Alignment | 2 | 2013 | 2177 | 0.100 |
Why?
|
Neuronavigation | 1 | 2013 | 169 | 0.100 |
Why?
|
Neurology | 1 | 2020 | 786 | 0.100 |
Why?
|
Hippocampus | 2 | 2001 | 3784 | 0.100 |
Why?
|
Hand | 1 | 2017 | 912 | 0.100 |
Why?
|
Prefrontal Cortex | 2 | 2020 | 2257 | 0.100 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12775 | 0.100 |
Why?
|
Larynx | 1 | 2016 | 492 | 0.090 |
Why?
|
Research | 1 | 2020 | 1981 | 0.090 |
Why?
|
Catheters, Indwelling | 1 | 2013 | 436 | 0.090 |
Why?
|
Potassium Channels | 1 | 1993 | 538 | 0.090 |
Why?
|
Spasm | 1 | 2011 | 131 | 0.090 |
Why?
|
Nerve Growth Factors | 1 | 1993 | 564 | 0.090 |
Why?
|
Physical Therapy Modalities | 1 | 2014 | 533 | 0.090 |
Why?
|
Prosencephalon | 1 | 2012 | 306 | 0.090 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2010 | 418 | 0.090 |
Why?
|
Microscopy, Confocal | 4 | 2005 | 1972 | 0.090 |
Why?
|
Cell Nucleus | 2 | 2016 | 2887 | 0.090 |
Why?
|
Diffusion | 1 | 2012 | 818 | 0.090 |
Why?
|
Nucleic Acid Conformation | 1 | 2013 | 900 | 0.090 |
Why?
|
Acetylcholine | 2 | 2009 | 629 | 0.080 |
Why?
|
Mice, Transgenic | 8 | 2015 | 9563 | 0.080 |
Why?
|
Protein Biosynthesis | 1 | 2017 | 2094 | 0.080 |
Why?
|
Thalamus | 1 | 2016 | 1050 | 0.080 |
Why?
|
Laryngeal Diseases | 2 | 2024 | 248 | 0.080 |
Why?
|
Genes, Reporter | 1 | 2013 | 1524 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2021 | 3457 | 0.080 |
Why?
|
Affect | 1 | 2017 | 1501 | 0.080 |
Why?
|
RNA, Messenger | 5 | 2018 | 12801 | 0.080 |
Why?
|
Spectrometry, Fluorescence | 2 | 2001 | 694 | 0.080 |
Why?
|
Neurons | 5 | 2018 | 9512 | 0.080 |
Why?
|
Motor Skills | 1 | 2012 | 523 | 0.080 |
Why?
|
Psychiatry | 1 | 2021 | 1715 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 2487 | 0.070 |
Why?
|
alpha-Synuclein | 4 | 2002 | 768 | 0.070 |
Why?
|
Medical Records | 1 | 2013 | 1413 | 0.070 |
Why?
|
Child | 11 | 2025 | 80894 | 0.070 |
Why?
|
Genetic Testing | 2 | 2016 | 3587 | 0.070 |
Why?
|
Molecular Sequence Data | 4 | 2013 | 17626 | 0.070 |
Why?
|
Child, Preschool | 6 | 2025 | 42654 | 0.070 |
Why?
|
Animals | 17 | 2021 | 169322 | 0.070 |
Why?
|
Introns | 2 | 2020 | 968 | 0.070 |
Why?
|
Base Sequence | 2 | 2018 | 12421 | 0.070 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 13019 | 0.070 |
Why?
|
Calcium Channels, N-Type | 1 | 2006 | 42 | 0.070 |
Why?
|
Probability | 1 | 2012 | 2482 | 0.070 |
Why?
|
Prognosis | 2 | 2021 | 30020 | 0.060 |
Why?
|
Neurogenesis | 1 | 2012 | 864 | 0.060 |
Why?
|
Cohort Studies | 4 | 2021 | 41791 | 0.060 |
Why?
|
Neuronal Plasticity | 2 | 2016 | 1448 | 0.060 |
Why?
|
Rotarod Performance Test | 1 | 2005 | 63 | 0.060 |
Why?
|
Gene Order | 2 | 2017 | 167 | 0.060 |
Why?
|
Risk Assessment | 2 | 2021 | 24316 | 0.060 |
Why?
|
Immunohistochemistry | 5 | 2005 | 11117 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2021 | 4286 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 1 | 2013 | 3728 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2012 | 2727 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4450 | 0.060 |
Why?
|
Energy Transfer | 2 | 2001 | 109 | 0.060 |
Why?
|
Disease Models, Animal | 8 | 2016 | 18358 | 0.060 |
Why?
|
Dysarthria | 1 | 2024 | 57 | 0.060 |
Why?
|
Quality of Life | 3 | 2020 | 13499 | 0.050 |
Why?
|
Apoptosis | 2 | 2020 | 9506 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2017 | 17132 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2024 | 65365 | 0.050 |
Why?
|
Gene Frequency | 1 | 2010 | 3615 | 0.050 |
Why?
|
Mice | 12 | 2021 | 82004 | 0.050 |
Why?
|
Genetic Markers | 2 | 2016 | 2604 | 0.050 |
Why?
|
Aged | 9 | 2024 | 171544 | 0.050 |
Why?
|
Twin Studies as Topic | 1 | 2002 | 103 | 0.050 |
Why?
|
Pedigree | 2 | 2022 | 4545 | 0.050 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2009 | 1143 | 0.050 |
Why?
|
Sex Chromosome Aberrations | 1 | 2002 | 116 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4675 | 0.050 |
Why?
|
Neuropil | 1 | 2001 | 31 | 0.050 |
Why?
|
Alternative Splicing | 2 | 2018 | 1093 | 0.050 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.050 |
Why?
|
Protein Conformation | 3 | 2011 | 3957 | 0.050 |
Why?
|
Interneurons | 1 | 2006 | 593 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3541 | 0.050 |
Why?
|
Host Cell Factor C1 | 1 | 2021 | 35 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 1 | 2012 | 2426 | 0.050 |
Why?
|
Neurodegenerative Diseases | 2 | 2007 | 1094 | 0.050 |
Why?
|
YY1 Transcription Factor | 1 | 2021 | 60 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6876 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2018 | 1889 | 0.050 |
Why?
|
Ligases | 1 | 2002 | 333 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2022 | 293 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4250 | 0.040 |
Why?
|
Ornithine | 1 | 2020 | 79 | 0.040 |
Why?
|
Haplotypes | 2 | 2018 | 2724 | 0.040 |
Why?
|
Inflammation | 1 | 2020 | 10863 | 0.040 |
Why?
|
Telomere-Binding Proteins | 1 | 2021 | 121 | 0.040 |
Why?
|
Chromosomes, Human, X | 1 | 2002 | 320 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6892 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2741 | 0.040 |
Why?
|
Intermediate Filaments | 1 | 2020 | 171 | 0.040 |
Why?
|
Muscle Hypotonia | 1 | 2021 | 166 | 0.040 |
Why?
|
Genes, Recessive | 1 | 2002 | 625 | 0.040 |
Why?
|
Leukocyte Elastase | 1 | 2020 | 114 | 0.040 |
Why?
|
Functional Laterality | 1 | 2006 | 2268 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2002 | 856 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2016 | 13425 | 0.040 |
Why?
|
Gliosis | 1 | 2020 | 246 | 0.040 |
Why?
|
Gait | 1 | 2024 | 822 | 0.040 |
Why?
|
Heat-Shock Proteins | 1 | 2002 | 797 | 0.040 |
Why?
|
Endocrine System Diseases | 1 | 2020 | 250 | 0.040 |
Why?
|
Gait Disorders, Neurologic | 1 | 2020 | 243 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2016 | 36849 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 433 | 0.040 |
Why?
|
Acetylation | 1 | 2020 | 1053 | 0.040 |
Why?
|
Excitatory Postsynaptic Potentials | 2 | 2009 | 369 | 0.040 |
Why?
|
Alu Elements | 1 | 2018 | 116 | 0.040 |
Why?
|
Minisatellite Repeats | 1 | 2018 | 164 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8241 | 0.040 |
Why?
|
Peroxidase | 1 | 2020 | 609 | 0.030 |
Why?
|
Antiparkinson Agents | 1 | 2018 | 184 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10377 | 0.030 |
Why?
|
Risk Factors | 3 | 2024 | 74954 | 0.030 |
Why?
|
Rare Diseases | 1 | 2022 | 630 | 0.030 |
Why?
|
Fetal Growth Retardation | 1 | 2020 | 591 | 0.030 |
Why?
|
Autopsy | 1 | 2020 | 1013 | 0.030 |
Why?
|
Hospitals, General | 1 | 2021 | 807 | 0.030 |
Why?
|
Brain Mapping | 1 | 2012 | 6740 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2025 | 15939 | 0.030 |
Why?
|
Activating Transcription Factor 4 | 1 | 2016 | 86 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2021 | 615 | 0.030 |
Why?
|
Educational Status | 1 | 2024 | 2518 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 962 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2020 | 1390 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14736 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2002 | 1780 | 0.030 |
Why?
|
Electroencephalography | 1 | 2011 | 6317 | 0.030 |
Why?
|
Patch-Clamp Techniques | 2 | 2009 | 927 | 0.030 |
Why?
|
Growth Substances | 1 | 2017 | 761 | 0.030 |
Why?
|
Time Factors | 2 | 2013 | 40267 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26373 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2013 | 39405 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2021 | 14481 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2820 | 0.030 |
Why?
|
Family | 2 | 2018 | 3208 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2021 | 1158 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2025 | 2661 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2002 | 4622 | 0.030 |
Why?
|
Reference Values | 1 | 2001 | 4941 | 0.030 |
Why?
|
Transfection | 3 | 2011 | 5758 | 0.030 |
Why?
|
PC12 Cells | 1 | 1993 | 317 | 0.030 |
Why?
|
Nerve Degeneration | 1 | 2018 | 749 | 0.030 |
Why?
|
DNA | 2 | 2021 | 7211 | 0.030 |
Why?
|
Computer Simulation | 2 | 2020 | 6277 | 0.030 |
Why?
|
Incidence | 1 | 2011 | 21544 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2002 | 1902 | 0.030 |
Why?
|
Astrocytes | 1 | 2020 | 1349 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2012 | 223 | 0.020 |
Why?
|
Video Recording | 1 | 2017 | 974 | 0.020 |
Why?
|
Protein Binding | 2 | 2020 | 9346 | 0.020 |
Why?
|
DNA Repair | 1 | 2021 | 2050 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2017 | 1748 | 0.020 |
Why?
|
Nuclear Localization Signals | 1 | 2011 | 78 | 0.020 |
Why?
|
Molecular Weight | 1 | 1993 | 2172 | 0.020 |
Why?
|
Microglia | 1 | 2020 | 1374 | 0.020 |
Why?
|
Cell Shape | 1 | 2012 | 371 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 1732 | 0.020 |
Why?
|
Demography | 1 | 2016 | 1642 | 0.020 |
Why?
|
Infant | 1 | 2013 | 36512 | 0.020 |
Why?
|
Cell Fractionation | 1 | 2011 | 247 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2268 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1743 | 0.020 |
Why?
|
Sex Factors | 1 | 2025 | 10656 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6238 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2011 | 455 | 0.020 |
Why?
|
Nomifensine | 1 | 2010 | 14 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2024 | 12457 | 0.020 |
Why?
|
Dominance, Cerebral | 1 | 2012 | 624 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5792 | 0.020 |
Why?
|
Parents | 1 | 2024 | 3596 | 0.020 |
Why?
|
Microdialysis | 1 | 2010 | 163 | 0.020 |
Why?
|
Dimerization | 1 | 2011 | 886 | 0.020 |
Why?
|
Disease Progression | 2 | 2020 | 13646 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2020 | 81768 | 0.020 |
Why?
|
Miniature Postsynaptic Potentials | 1 | 2009 | 17 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2015 | 2695 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 1943 | 0.020 |
Why?
|
Acetylcholinesterase | 1 | 2009 | 151 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2020 | 3139 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3092 | 0.020 |
Why?
|
Inhibitory Postsynaptic Potentials | 1 | 2009 | 62 | 0.020 |
Why?
|
Amphetamine | 1 | 2010 | 225 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2012 | 916 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 1833 | 0.020 |
Why?
|
Cytosol | 1 | 2011 | 886 | 0.020 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2010 | 298 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3627 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3442 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6512 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2474 | 0.020 |
Why?
|
Radioligand Assay | 1 | 2007 | 367 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5800 | 0.020 |
Why?
|
Proteins | 1 | 2021 | 6006 | 0.020 |
Why?
|
Plasmids | 1 | 2011 | 2267 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2010 | 1539 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2012 | 1428 | 0.020 |
Why?
|
Kinetics | 1 | 1993 | 6334 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2007 | 1142 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2011 | 1395 | 0.020 |
Why?
|
Antibodies | 1 | 1993 | 2425 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3666 | 0.020 |
Why?
|
Cell Division | 1 | 2012 | 4478 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 19019 | 0.020 |
Why?
|
Presynaptic Terminals | 1 | 2007 | 302 | 0.020 |
Why?
|
Epitopes | 1 | 2011 | 2525 | 0.010 |
Why?
|
Cell Membrane | 1 | 1993 | 3663 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 2006 | 796 | 0.010 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 6132 | 0.010 |
Why?
|
Dopamine Agonists | 1 | 2006 | 353 | 0.010 |
Why?
|
Transgenes | 1 | 2007 | 1015 | 0.010 |
Why?
|
Gestational Age | 1 | 2012 | 3615 | 0.010 |
Why?
|
Calcium Channel Blockers | 1 | 2006 | 692 | 0.010 |
Why?
|
Glutamic Acid | 1 | 2009 | 1193 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59683 | 0.010 |
Why?
|
Rats | 2 | 2002 | 23833 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 2005 | 1629 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 22355 | 0.010 |
Why?
|
Gene Library | 1 | 2005 | 1061 | 0.010 |
Why?
|
Models, Biological | 1 | 2017 | 9494 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2012 | 3612 | 0.010 |
Why?
|
Models, Molecular | 1 | 2011 | 5408 | 0.010 |
Why?
|
Inclusion Bodies | 1 | 2002 | 279 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15868 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5916 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2001 | 423 | 0.010 |
Why?
|
Cell Movement | 1 | 2012 | 5214 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2001 | 527 | 0.010 |
Why?
|
COS Cells | 1 | 2002 | 1135 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2002 | 1435 | 0.010 |
Why?
|
Ligands | 1 | 2007 | 3283 | 0.010 |
Why?
|
Linear Models | 1 | 2010 | 5878 | 0.010 |
Why?
|
Synapses | 1 | 2009 | 1766 | 0.010 |
Why?
|
Action Potentials | 1 | 2006 | 1838 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2002 | 2559 | 0.010 |
Why?
|
Protein Folding | 1 | 2002 | 872 | 0.010 |
Why?
|
Cell Line | 2 | 2002 | 15593 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18472 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1684 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10776 | 0.010 |
Why?
|
United States | 1 | 2024 | 73144 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2001 | 3060 | 0.010 |
Why?
|
Blotting, Western | 1 | 2001 | 5033 | 0.010 |
Why?
|
Transcription Factors | 1 | 2012 | 12166 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2002 | 8198 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4981 | 0.010 |
Why?
|
Glioma | 1 | 2001 | 3526 | 0.000 |
Why?
|
Alzheimer Disease | 1 | 2002 | 8747 | 0.000 |
Why?
|